United States: FDA Provides Updated Instructions For Reporting Serious Adverse Events Under MoCRA - Crowell & Moring LLP

Mondaq

29 Jan 2024 0 shares 1 views

United States: FDA Provides Updated Instructions For Reporting Serious Adverse Events Under MoCRA - Crowell & Moring LLP

Mondaq

Published 29 Jan 2024

On December 14, 2023, the FDA issued an update with further instructions on serious adverse event reporting under the Modernization of Cosmetics Regulation Act of 2022 ("MoCRA")...

Full Article

United States: FDA Launches Cosmetics Direct, Issues Final Guidance On Registration And Listing Of Cosmetic Product Facilities And Products Under MoCRA, And Updates Instructions For Serious Adverse Event Reporting For Cosmetic Products - Venable LLP

Last week, the U.S. Food and Drug Administration (FDA) launched Cosmetics Direct, a new electronic submission portal for the..

Mondaq 08 Jan 2024

United States: FDA Provides Updated Instructions For Reporting Serious Adverse Events Under MoCRA - Crowell & Moring LLP

United States: FDA Provides Updated Instructions For Reporting Serious Adverse Events Under MoCRA - Crowell & Moring LLP

You might like

Related news coverage

United States: FDA Launches Cosmetics Direct, Issues Final Guidance On Registration And Listing Of Cosmetic Product Facilities And Products Under MoCRA, And Updates Instructions For Serious Adverse Event Reporting For Cosmetic Products - Venable LLP

Advertisement